Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option

Medios AG / Key word(s): Capital Increase
Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option

03-Dec-2021 / 08:01 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER COUNTRIES WHERE SUCH DISTRIBUTION OR PUBLICATION MIGHT BE UNLAWFUL

Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option

Berlin, December 3, 2021 - Medios AG (the "Company") has placed a total of 2,026,499 new no-par value bearer shares ("New Shares") at a price of €35.50 per share with institutional investors as part of the cash capital increase announced yesterday. This capital increase makes partial use of the Authorized Capital 2021 and excludes shareholders' subscription rights. Following the implementation of the cash capital increase, the Company's share capital will increase from €20,264,991.00 by €2,026,499.00, or approx. 10.0%, to €22,291,490.00. The Company will receive gross proceeds from the capital increase of approximately €72m.

Due to significant investor demand, the upsize option was exercised in full extent and all additional shares were successfully placed. The 590,000 additional new shares will be created making use of the Conditional Capital 2017 and are part of the Stock Option Plan 2017, which allows members of the Management Board and senior executives to exercise subscription rights during specified limited time windows.

In total, the Company has placed 2,616,499 New Shares at a price of €35.50 per share making use of the Authorized Capital 2021 and the Conditional Capital 2017. The share capital of the Company thus increases to €22,881,490.00.

Notifying person: Matthias Gaertner, Chief Executive Officer of Medios AG

Contact
Medios AG, Heidestraße 9, 10557 Berlin, Germany
Phone: +49 30 232 5668 00; Fax: +49 30 232 5668 01
E-mail: ir@medios.ag; www.medios.ag

About Medios AG
Medios AG is the leading provider of Specialty Pharma solutions in Germany. As a competence partner and expert, Medios covers all relevant aspects of the supply chain in this field: from pharmaceutical supply to the manufacture of patient-specific therapies including blistering. The focus is on optimal patient care via specialized pharmacies.

Medios AG is Germany's first listed Specialty Pharma company. The shares (ISIN: DE000A1MMCC8) are listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).

Contact
Claudia Nickolaus
Head of Investor & Public Relations
Medios AG
Heidestraße 9 | 10557 Berlin | Germany
P +49 30 232 566 800
c.nickolaus@medios.ag
www.medios.ag

Disclaimer
This notification is a mandatory notification according to Art. 17 MAR. Medios AG is solely responsible for the content of this announcement. As always, the assessments contained herein are subject to the reservations stated below.

Reservation on future statements/no obligation to update
This release contains forward-looking statements that are subject to certain risks and uncertainties. Future results could differ materially from those currently anticipated due to various risk factors and uncertainties, including changes in business, economic and competitive conditions, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Medios AG assumes no responsibility whatsoever to update the forward-looking statements contained in this release.

Note
This release may not be distributed or published in the United States of America (including its territories and possessions), Canada, Japan or Australia or any other countries where such publication may be unlawful. The distribution of this publication may be subject to legal restrictions in some countries and anyone in possession of this document or the information referred to herein should inform themselves about and observe any such restrictions. Failure to comply with such restrictions may constitute a violation of capital market laws of such countries.

This announcement is neither an offer nor a solicitation to subscribe for or purchase securities of Medios AG in the United States of America, Germany or any other country. No public offer has been or will be made and no prospectus will be published in connection with this transaction.

Neither this publication nor its contents may be used as the basis for an offer in any country. The aforementioned securities may not be sold or offered for sale in the United States of America absent registration or an exemption from registration under the United States Securities Act of 1933, as amended (the 'Securities Act'). The securities of Medios AG are not and will not be registered under the Securities Act.

This announcement does not constitute a recommendation regarding the placement of the securities described in this announcement. Investors should consult a professional advisor as to the suitability of the offer for the person concerned.

In the United Kingdom, this publication is directed only at (i) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the 'Order'), as amended, or (ii) persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, partnerships, etc.) (such persons together being referred to as 'Relevant Persons'). No persons other than Relevant Persons may refer to or rely on this publication. Any investment or investment opportunity referred to in this publication is available only to Relevant Persons and will be engaged in only with Relevant Persons.

The offer referred to herein, which is made in Member States of the European Economic Area (each a 'Relevant Member State') is only addressed to 'qualified investors' within the meaning of Article 2 (e) of the Prospectus Regulation ('Qualified Investors'). For these purposes, the term 'Prospectus Regulation' means Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC, and also includes the delegated regulations in this regard.

No measures have been taken that would permit the offer of the securities, their acquisition or the distribution of this publication in countries where this is not permitted. Anyone who comes into possession of this publication must inform themselves about any restrictions and observe them.

Miscellaneous
This publication is neither an offer to sell nor a solicitation to buy securities. This announcement may not be distributed or published in the United States of America (including its territories and possessions), Canada, Japan or Australia or any other countries in which such publication may be unlawful. This announcement does not constitute a recommendation to buy or sell the securities described in this announcement.

03-Dec-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de